drugset / Trial / NCT02367911

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis

NCT02367911 ↗

Phase 3 Completed 144 enrolled Therapeutics, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This Phase 3 study has been designed to determine and compare the efficacy and safety of 122-0551 Foam and Vehicle Foam applied twice daily for two weeks in subjects with plaque psoriasis.

Timeline

Start
2015-01
Primary completion
2015-08
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject 122-0551 Foam Unknown — Topical

Indications